Skip to main content
. Author manuscript; available in PMC: 2009 Apr 21.
Published in final edited form as: J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):176–181. doi: 10.1097/QAI.0b013e3181938e7e

FIGURE 1.

FIGURE 1

Virological outcomes at the end of the intervention and at 6 months postintervention. Proportion of subjects achieving virological success (HIV-1 RNA ≤400 copies/mL or a1.0 log10 reduction in HIV-1 RNA). Note: reported P values are adjusted for baseline viral load and CD4 counts.